Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sif orders PEMA plate joining lines for XXXL monopile manufacturing

Sif's production site at Maasvlakte 2-Rotterdam. The company is specialized in foundation design, fabrication, corrosion protection, and logistics services for offshore wind farm developers and EPCI contractors. Photo: Sif Holding N.V. Pemamek Ltd. has won a significant order to supply PEMA production automation solutions to the Dutch offshore wind monopile foundation manufacturer Sif Holding N.V. (Sif). The delivery includes PEMA plate joining lines for XXXL monopile foundation manufacturing and extensive service agreements. Based on innovative and sophisticated production

Kindred expands North American retail footprint by launching in Washington State

Kindred Group continues its North American retail expansion by launching phase one of its partnership with The Swinomish Tribe, Washington State.Kindred Group plc (Kindred) launches a retail operation at the Swinomish Casino & Lodge. This follows the announcement of the six-year agreement with the Swinomish Indian Tribal Community in October 2022. The first phase of the Sportsbook launch includes Unibet branded kiosks and over-the-counter sports betting. Further development will include an immersive Unibet sports betting lounge, due to launch later this year. Unibet Sportsbook at

Autoliv expands to Vietnam and invests in new airbag cushion plant

(Stockholm, Sweden, April 20, 2023) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced its plan to build a new state of the art airbag cushion and fabric plant in Vietnam, serving Asia. The investment in the new textile facility is in response to customer demands and is intended to meet expanded future airbag production needs for the growing Asia market.The new facility will be built in Amata City Ha Long Industrial Park, located in the northern part of Vietnam. The facility will showcase Autoliv's manufacturing capabilities

Tomi Alén becomes Partner at CapMan Growth

CapMan Growth press release 20.04.2023 at 9.00 AM EEST Tomi Alén becomes Partner at CapMan Growth Tomi Alén has been appointed as Partner at CapMan Growth as of 5.6.2023. Alén joins CapMan from one of Finland’s top growth companies, RELEX Solutions, where he has for the past two years worked in the role of Senior Vice President Strategy and Corporate Development as part of the company’s extended leadership team. Alén has led the team focusing on the company’s strategy, strategic initiatives, add-on acquisitions, fundraising and investor relations. Through his new role

Viaplay launches on Roku devices in the US, Canada and the UK

· Viewers in North America and the UK can subscribe directly to Viaplay on Roku devices · Roku is the No. 1 TV streaming platform in the US and Canada by hours streamed · Viaplay joined The Roku Channel’s US Premium Subscriptions offering in December Viaplay Group and Roku have agreed a multi-year partnership that makes the Viaplay streaming service available for subscription through Roku devices in the US, Canada and the UK. Viewers in all three countries can now subscribe directly to Viaplay’s full local offerings via Roku, which is the No. 1 TV streaming platform in the US and

MSAB´s annual report for 2022 published

The Swedish version of MSAB's annual report 2022 is now available for download on the company’s website: www.msab.comThe English version of the annual report is expected to be available on MSAB's website on April 22, 2023.This information is information that MSAB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication of the contact person set out below, on April 20, 2023, 08:00 am (CEST).

Ovzon Interim Report January–March 2023

Eventful start to 2023January–March 2023 · Revenue totaled SEK 57 million (100). Adjusted revenue totaled SEK 57 million (97) · Operating profit/loss totaled SEK -23 million (-18). Adjusted operating profit/loss totaled SEK -34 million (18) · Profit/loss after tax totaled SEK -19 million (-12) · Earnings per share totaled SEK -0.37 (-0.23) · Cash flow for the period totaled SEK -72 million (-96) Significant events during the quarter · Announcement regarding the delay of the launch of Ovzon 3, and switch to SpaceX as launch partner · Carried out a directed share

Norse Atlantic ASA: Last day of the subscription period in the subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Arendal, 20 April 2023: Reference is made to the stock exchange announcement by Norse Atlantic ASA (the "Company") on 12 April 2023 regarding launch of the subsequent offering of up to 60,000,000 new shares in the Company at a subscription price of NOK

Olvi Group’s interim report January–March 2023

OLVI PLC                  Interim report 20 April 2023 at 9 am Olvi Group’s interim report January–March 2023 Net sales increased driven by strong demand, but purchase costs remained high · Net sales were EUR 129.5 (103.9) million. The sales volume increased by 7.6%, and net sales grew by 24.6%. · The adjusted operating result was EUR 10.0 (6.4) million, and the operating result was EUR -2.2 (6.4) million. The operating result includes an expense of EUR 12.2 million related to a fine imposed on the subsidiary in Belarus. · A strong balance sheet and a solid financial

Interim Report Safeture AB Q1 2023: Continued improved profitability

· Annual recurring revenue (ARR) growth of +27% to 44,0 MSEK. · Recurring revenue amounts to 10,7 MSEK compared to 8,1 MSEK last year (+31%). · EBIT improvement year-on-year of 2,2 MSEK, reaching -2,5 MSEK . · Bottom-line result at -23% of net sales compared to -57% one year ago. · Quarterly churn at 1,5% · Yearly NRR at 109%Classics First quarter (2023-01-01 to 2023-03-31) • Net revenue amounted to 10 668 (8 152) TSEK (+31%). • Loss after financials amounted to -2 497 (-4 665) TSEK. • Loss per share before dilution amounted to -0,06 (-0,15) SEK. • Loss per

Polygiene Group AB (publ.) publishes Annual Report for 2022

The Annual Report 2022 for Polygiene Group AB (publ.) is now available at the company’s site ir.polygiene.com.  The Annual shareholder meeting will be held Thursday 11 May 2023 at 13.00 at STUDIO, Nordenskiöldsgatan 24, in Malmö.To download the annual report, visit ir.polygiene.com/financial-reportsFor more information contact:Niklas Blomstedt, CFOMobile: +46 (0) 70 663 21 26E-mail: niklas.blomstedt@polygiene.com                     Ulrika Björk, CEOMobile: +46 (0) 70 921 12 75E-mail: ulrika.bjork@polygiene.com This information was submitted for publication, through the

Hansa Biopharma interim report January–March 2023

· Positive reimbursement decision in Spain expands market access to include the five largest European markets · Enrollment in phase 2 study of imlifidase in Guillain-Barré Syndrome (GBS) completed · HNSA-5487: Phase 1 clinical study started in healthy volunteersLund, Sweden, April 20, 2023, Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and interim report for January to March 2023. Highlights for the first quarter of 2023 · Total Q1 revenue of SEK 24.2m including SEK 14.3m in product sales

AQ Group AB (publ), interim report January - March, 2023

First quarter, January-March 2023 in brief   · Good start of the year results in growth, improved margin, and cash flow · Net sales increased by 36.8% to SEK 2,253 million (1,646) · Operating profit (EBIT) increased by 72.3% to SEK 194 million (113) · Profit after financial items (EBT) increased by 58.3% to SEK 184 million (116) · Profit margin before tax (EBT %) was 8.2% (7.1) · Cash flow from operating activities amounted to SEK 225 million (44) · Earnings per share after dilution increased by 70.2% to SEK 8.58 (5.04) · Equity ratio was 55% (56) · The Board

Publication of Genetic Analysis’ 2022 Annual Report

(Oslo, April 20, 2023) Genetic Analysis AS (“GA” or “the Company”) hereby publishes the Annual Report for the financial year of 2022. The Annual Report is available as an attached file to this release and on the Company’s website (www.genetic-analysis.com).For further information, please contact:Ronny Hermansen, CEOE-mail: rh@genetic-analysis.com Eilert Aamodt, Chief Financial OfficerE-mail: ea@genetic-analysis.com

Stora Enso lowers its guidance for the full-year 2023 due to worsening market outlook (inside information)

STORA ENSO OYJ INSIDE INFORMATION 20 April 2023 at 9:00 EESTStora Enso provided guidance in connection with its financial statement release 2022, published on 31 January 2023, that its full-year 2023 operational EBIT was expected to be lower than for the full-year 2022 (EUR 1,891 million).  Due to materially lower earnings forecasts for the full year results 2023, Stora Enso’s new guidance is that the full-year 2023 operational EBIT is expected to be significantly lower than for the full-year 2022 (EUR 1,891 million). The change in earnings expectations for the full year 2023 is a

Etteplan’s Board of Directors resolved on key personnel incentive plan

Etteplan Oyj, Stock Exchange Release, April 20, 2023, at 9.00 A.M. EEST Etteplan’s Board of Directors resolved on key personnel incentive plan Etteplan’s Board of Directors has resolved to establish a new share incentive plan for the Group key personnel. The aim of the share incentive plan is to combine the objectives of the shareholders and the key personnel in order to increase the value of Etteplan, to commit the key personnel to the company, and to offer them a competitive reward plan based on earning the company shares. The plan includes one earning period which includes

Neste to publish its first quarter results on 28 April 2023

Neste Corporation, Press Release, 20 April 2023 at 9 a.m. (EET) Neste will publish its first quarter 2023 results on Friday, 28 April 2023 at approximately 9 a.m. (EET). The release will be available on the Neste website  immediately after publishing. A conference call in English for investors and analysts will be held on 28 April 2023, at 3 p.m. Finland / 1 p.m. London / 8 a.m. New York. In order to receive the participant dial in numbers and a unique personal PIN, participants are requested to register using this link:  https://register.vevent.com/

EQL Pharma AB announces a recommended cash offer of SEK 7.60 per share to the shareholders of Sensidose Aktiebolag

This announcement is not an offer, neither directly or indirectly, in Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Singapore, South Africa or USA, or in any other jurisdiction where such offer pursuant to legislation, restrictions and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders are referred to the offer restrictions included in the section titled "

Preliminary result: Strong profit development during the first quarter

Fractal Gaming Group publishes preliminary results for the first quarter. Net sales are estimated at SEK 195.5m (117.5), an increase of 66.4%. EBITDA is estimated at SEK 41.6m (11.3), corresponding to an EBITDA margin of 21.3% (9.6). EBIT is estimated at SEK 36.5m (7.3), corresponding to an EBIT margin of 18.7% (6.2). "The first quarter's profit development has been stronger than expected, driven by high sales growth and a good product margin. As we communicated earlier, there is a pent-up need for new PC gaming equipment. The recovery in the market, which began in the second half of

Interim report 2023, January 1-March 31

January-March 2023 Net revenue for the period was SEK 310.5 million (162.4), an increase of 91.2%. Organic growth was 19.7%. Orders received for the period was SEK 340.3 million (130.8), an increase of 160.2%. Organic growth was 86.5%. EBITDA for the period was SEK 84.2 million (21.2) Profit/loss for the period was SEK 35.6 million (0.1) Earnings per share for the period amounted to SEK 0.20 (0.00) Cash flow from Operations for the period was SEK 125.8 million (1.8) Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) are mandated to investigate a potential

Elisa’s Interim Report Q1 2023

ELISA CORPORATION INTERIM REPORT RELEASE 20 APRIL 2023 AT 8:30 AMFirst quarter 2023 financial highlights · Revenue increased by EUR 28m to EUR 540m due to growth in mobile, fixed and digital services as well as equipment sales. · Mobile service revenue increased by 4.9 per cent to EUR 235m. · EBITDA grew by EUR 6m to EUR 183m. · EBIT increased by EUR 6m to EUR 117m. · Comparable cash flow increased by EUR 5m to EUR 71m, mainly due to higher EBITDA and lower negative change in net working capital. · In Finland, mobile post-paid ARPU increased to EUR 21.7 (21.5 in the

The last day of trading in the warrants of series TO3B in Scandinavian ChemoTech AB is today, April 20, 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES THAN SUCH MEASURES WHICH FOLLOWS FROM SWEDISH REGULATIONS.Today, April 20, 2023, is the last day of trading with the warrants of series TO3B in Scandinavian ChemoTech AB (“Scandinavian ChemoTech” or the “Company”). The subscription period for

Nixu Corporation: CEO´s review for Q1, 2023

Nixu Corporation, Stock Exhange release, April 20, 2023 at 8:30 AM EESTOne of the best financial results ever for Q1 in Nixu history Nixu Corporation´s unaudited revenue for January-March 2023 increased by 20 % from the corresponding period of the previous year and amounted to EUR 16.6 million (Q1/2022: EUR 13.8 million). EBIT was EUR 274 thousand (EUR -687 thousand). Adjusted EBIT was EUR 878 thousand (EUR -712 thousand). Financial guidance for 2023 Nixu repeats its financial guidance for 2023 published on February 9, 2023: Nixu estimates its revenue to be EUR 66-70 million and

There are no items matching the current filter
There are no more items matching the current filter
Back to top